-
1
-
-
0036255688
-
Targeted therapy of cancer with radiolabeled antibodies
-
Goldenberg, D. M. Targeted therapy of cancer with radiolabeled antibodies. J. Nucl. Med., 43: 693-713, 2002
-
(2002)
J. Nucl. Med
, vol.43
, pp. 693-713
-
-
Goldenberg, D.M.1
-
2
-
-
0028470454
-
Barriers to drug-delivery in solid tumors
-
Jain, R. K. Barriers to drug-delivery in solid tumors. Sci. Am., 271: 58-65, 1994
-
(1994)
Sci. Am
, vol.271
, pp. 58-65
-
-
Jain, R.K.1
-
3
-
-
0029114671
-
Targeting cancer micrometastases with monoclonal-antibodies-a binding-site barrier
-
Saga, T., Neumann, R. D., Heya, T., Sato, J., Kinuya, S., Le, N., Paik, C. H., and Weinstein, J. N. Targeting cancer micrometastases with monoclonal-antibodies-a binding-site barrier. Proc. Natl. Acad. Sci. USA, 92: 8999, 1995
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 8999
-
-
Saga, T.1
Neumann, R.D.2
Heya, T.3
Sato, J.4
Kinuya, S.5
Le, N.6
Paik, C.H.7
Weinstein, J.N.8
-
4
-
-
0026761554
-
New methods for localizing infection: A role for avidin-biotin?
-
Goodwin, D. A. New methods for localizing infection: A role for avidin-biotin? J. Nucl. Med., 33: 1816-1818, 1992
-
(1992)
J. Nucl. Med
, vol.33
, pp. 1816-1818
-
-
Goodwin, D.A.1
-
5
-
-
0026356523
-
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients
-
Paganelli, G., Magnani, P., Zito, F., Villa, E., Sudati, F., Lopalco, L., Rossetti, C., Malcovati, M., Chiolerio, F., Seccamani, E., and et al. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res. 51: 5960-5966, 1991
-
(1991)
Cancer Res
, vol.51
, pp. 5960-5966
-
-
Paganelli, G.1
Magnani, P.2
Zito, F.3
Villa, E.4
Sudati, F.5
Lopalco, L.6
Rossetti, C.7
Malcovati, M.8
Chiolerio, F.9
Seccamani, E.10
-
6
-
-
0026459501
-
Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: Theoretical, experimental and clinical results
-
Le Doussal, J. M., Barber, J., and Delaage, M. Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: Theoretical, experimental and clinical results. Int. J. Cancer (Suppl.), 7: 58-62, 1992
-
(1992)
Int. J. Cancer (Suppl.)
, vol.7
, pp. 58-62
-
-
Le Doussal, J.M.1
Barber, J.2
Delaage, M.3
-
8
-
-
0033963824
-
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer
-
Knox, S. J., Goris, M. L., Tempero, M., Weiden, P. L., Gentner, L., Breitz, H., Adams, G. P., Axworthy, D., Gaffigan, S., Bryan, K., Fisher, D. R., Colcher, D., Horak, I. D., and Weiner, L. M. Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. Clin. Cancer Res., 6: 406-414, 2000
-
(2000)
Clin. Cancer Res
, vol.6
, pp. 406-414
-
-
Knox, S.J.1
Goris, M.L.2
Tempero, M.3
Weiden, P.L.4
Gentner, L.5
Breitz, H.6
Adams, G.P.7
Axworthy, D.8
Gaffigan, S.9
Bryan, K.10
Fisher, D.R.11
Colcher, D.12
Horak, I.D.13
Weiner, L.M.14
-
9
-
-
0033972577
-
Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin
-
Breitz, H. B., Weiden, P. L., Beaumier, P. L., Axworthy, D. B., Seller, C., Su, F. M., Graves, S., Bryan, K., and Reno, J. M. Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin. J. Nucl. Med., 41: 131-140, 2000
-
(2000)
J. Nucl. Med
, vol.41
, pp. 131-140
-
-
Breitz, H.B.1
Weiden, P.L.2
Beaumier, P.L.3
Axworthy, D.B.4
Seller, C.5
Su, F.M.6
Graves, S.7
Bryan, K.8
Reno, J.M.9
-
10
-
-
12944301124
-
Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity
-
Axworthy, D. B., Reno, J. M., Hylarides, M. D., Mallett, R. W., Theodore, L. J., Gustavson, L. M., Su, F., Hobson, L. J., Beaumier, P. L., and Fritzberg, A. R. Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. Proc. Natl. Acad. Sci. USA. 97: 1802-1807, 2000
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 1802-1807
-
-
Axworthy, D.B.1
Reno, J.M.2
Hylarides, M.D.3
Mallett, R.W.4
Theodore, L.J.5
Gustavson, L.M.6
Su, F.7
Hobson, L.J.8
Beaumier, P.L.9
Fritzberg, A.R.10
-
11
-
-
0025826197
-
Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas
-
Pastan, I., Lovelace, E. T., Gallo, M. G., Rutherford, A. V., Magnani, J. L., and Willingham, M. C. Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. Cancer Res., 51: 3781-3787, 1991
-
(1991)
Cancer Res
, vol.51
, pp. 3781-3787
-
-
Pastan, I.1
Lovelace, E.T.2
Gallo, M.G.3
Rutherford, A.V.4
Magnani, J.L.5
Willingham, M.C.6
-
12
-
-
17444453362
-
Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3
-
Pai-Scherf, L. H., Carrasquillo, J. A., Paik, C., Gansow, O., Whatley, M., Pearson, D., Webber, K., Hamilton, M., Allegra, C., Brechbiel, M., Willingham, M. C., and Pastan, I. Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3. Clin. Cancer Res., 6: 1720-1730, 2000
-
(2000)
Clin. Cancer Res
, vol.6
, pp. 1720-1730
-
-
Pai-Scherf, L.H.1
Carrasquillo, J.A.2
Paik, C.3
Gansow, O.4
Whatley, M.5
Pearson, D.6
Webber, K.7
Hamilton, M.8
Allegra, C.9
Brechbiel, M.10
Willingham, M.C.11
Pastan, I.12
-
13
-
-
85008330124
-
-
Biotinidase-resistant biotin DOTA conjugates. United States Patent 5608060, 1997
-
Axworthy, D., Theodore, L. J., Gustavson, L. M., and Reno, J. M. Biotinidase-resistant biotin DOTA conjugates. United States Patent 5608060, 1997
-
-
-
Axworthy, D.1
Theodore, L.J.2
Gustavson, L.M.3
Reno, J.M.4
-
15
-
-
0024570173
-
Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer
-
Wilbur, D. S., Hadley, S. W., Hylarides, M. D., Abrams, P. G., Beaumier, P. A., Morgan, A. C., Reno, J. M., and Fritzberg, A. R. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J. Nucl. Med., 30: 216-226, 1989
-
(1989)
J. Nucl. Med
, vol.30
, pp. 216-226
-
-
Wilbur, D.S.1
Hadley, S.W.2
Hylarides, M.D.3
Abrams, P.G.4
Beaumier, P.A.5
Morgan, A.C.6
Reno, J.M.7
Fritzberg, A.R.8
-
16
-
-
0027336494
-
Preclinical evaluation of 111In-labeled B3 monoclonal antibody: Biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts
-
Camera, L., Kinuya, S., Pai, L. H., Garmestani, K., Brechbiel, M. W., Gansow, O. A., Paik, C. H., Pastan, I., and Carrasquillo, J. A. Preclinical evaluation of 111In-labeled B3 monoclonal antibody: Biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts. Cancer Res., 53: 2834-2839, 1993
-
(1993)
Cancer Res
, vol.53
, pp. 2834-2839
-
-
Camera, L.1
Kinuya, S.2
Pai, L.H.3
Garmestani, K.4
Brechbiel, M.W.5
Gansow, O.A.6
Paik, C.H.7
Pastan, I.8
Carrasquillo, J.A.9
-
18
-
-
0030002992
-
MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine
-
Stabin, M. G. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J. Nucl. Med., 37: 538-546, 1996
-
(1996)
J. Nucl. Med
, vol.37
, pp. 538-546
-
-
Stabin, M.G.1
-
19
-
-
0024815233
-
A humanized antibody that binds to the interleukin 2 receptor
-
Queen, C., Schneider, W. P., Selick, H. E., Payne, P. W., Landolfi, N. F., Duncan, J. F., Avdalovic, N. M., Levitt, M., Junghans, R. P., and Waldmann, T. A. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA, 86: 10029-10033, 1989
-
(1989)
Proc. Natl. Acad. Sci. USA
, vol.86
, pp. 10029-10033
-
-
Queen, C.1
Schneider, W.P.2
Selick, H.E.3
Payne, P.W.4
Landolfi, N.F.5
Duncan, J.F.6
Avdalovic, N.M.7
Levitt, M.8
Junghans, R.P.9
Waldmann, T.A.10
-
20
-
-
0027958499
-
Comparative toxicity studies of yttrium-90 MX-DTPA and 2-1T-BAD conjugated monoclonal antibody (BrE-3)
-
DeNardo, G. L., Kroger, L. A., DeNardo, S. J., Miers, L. A., Salako, Q., Kukis, D. L., Fand, I., Shen, S., Renn, O., and Meares, C. F. Comparative toxicity studies of yttrium-90 MX-DTPA and 2-1T-BAD conjugated monoclonal antibody (BrE-3). Cancer (Phila), 73: 1012-1022, 1994
-
(1994)
Cancer (Phila.)
, vol.73
, pp. 1012-1022
-
-
DeNardo, G.L.1
Kroger, L.A.2
DeNardo, S.J.3
Miers, L.A.4
Salako, Q.5
Kukis, D.L.6
Fand, I.7
Shen, S.8
Renn, O.9
Meares, C.F.10
|